Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity

1Maréchal A, Zou L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol 2013; 5: a012716. doi: 10.1101/cshperspect.a012716Maréchal A Zou L DNA damage sensing by the ATM and ATR kinases Cold Spring Harb Perspect Biol 2013 5 a012716 10.1101/cshperspect.a012716375370724003211Open DOISearch in Google Scholar

2Eriksson D, Stigbrand T. Radiation-induced cell death mechanisms. Tumor Biol 2010; 31: 363-72. doi: 10.1007/s13277-010-0042-8Eriksson D Stigbrand T Radiation-induced cell death mechanisms Tumor Biol 2010 31 363 72 10.1007/s13277-010-0042-820490962Open DOISearch in Google Scholar

3Lomax ME, Folkes LK, O’Neill P. Biological consequences of radiation-induced DNA damage: relevance to radiotherapy. Clin Oncol 2013; 25: 578-85. doi: 10.1016/j.clon.2013.06.007Lomax ME Folkes LK O’Neill P Biological consequences of radiation-induced DNA damage: relevance to radiotherapy Clin Oncol 2013 25 578 85 10.1016/j.clon.2013.06.00723849504Open DOISearch in Google Scholar

4Hu J, Lieb JD, Sancar A, Adar S. Cisplatin DNA damage and repair maps of the human genome at single-nucleotide resolution. Proc Natl Acad Sci 2016; 13: 11507-12. doi: 10.1073/pnas.1614430113Hu J Lieb JD Sancar A Adar S Cisplatin DNA damage and repair maps of the human genome at single-nucleotide resolution Proc Natl Acad Sci 2016 13 11507 12 10.1073/pnas.1614430113506833727688757Open DOISearch in Google Scholar

5Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, et al. Molecular mechanisms of cisplatin resistance. Oncogene 2012; 31: 1869-83. doi: 10.1038/onc.2011.384Galluzzi L Senovilla L Vitale I Michels J Martins I Kepp O et al Molecular mechanisms of cisplatin resistance Oncogene 2012 31 1869 83 10.1038/onc.2011.38421892204Open DOISearch in Google Scholar

6Makovec T. Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy. Radiol Oncol 2019; 53: 148-58. doi: 10.2478/raon-2019-0018Makovec T Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy Radiol Oncol 2019 53 148 58 10.2478/raon-2019-0018657249530956230Open DOISearch in Google Scholar

7Chen J, Stubbe J. Bleomycins: towards better therapeutics. Nat Rev Cancer 2005; 5: 102-12. doi: 10.1038/nrc1547Chen J Stubbe J Bleomycins: towards better therapeutics Nat Rev Cancer 2005 5 102 12 10.1038/nrc154715685195Open DOISearch in Google Scholar

8Allawzi A, Elajaili H, Redente EF, Nozik-Grayck E. Oxidative toxicology of bleomycin: role of the extracellular redox environment. Physiol Behav 2016; 176: 139-48. doi: 10.1016/j.cotox.2018.08.001Allawzi A Elajaili H Redente EF Nozik-Grayck E Oxidative toxicology of bleomycin: role of the extracellular redox environment Physiol Behav 2016 176 139 48 10.1016/j.cotox.2018.08.001661575231289762Open DOISearch in Google Scholar

9Strojan P, Corry J, Eisbruch A, Vermorken JB, Mendenhall WM, Lee AWM, et al. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head Neck 2015; 37: 134-50. doi: 10.1002/hed.23542Strojan P Corry J Eisbruch A Vermorken JB Mendenhall WM Lee AWM et al Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate Head Neck 2015 37 134 50 10.1002/hed.2354224481720Open DOISearch in Google Scholar

10Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol 2011; 100: 33-40. doi: 10.1016/j.radonc.2011.05.036Blanchard P Baujat B Holostenco V Bourredjem A Baey C Bourhis J et al Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site Radiother Oncol 2011 100 33 40 10.1016/j.radonc.2011.05.03621684027Open DOISearch in Google Scholar

11Benson E, Li R, Eisele D, Fakhry C. The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol 2014; 50: 56574. doi: 10.1016/j.oraloncology.2013.09.008Benson E Li R Eisele D Fakhry C The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas Oral Oncol 2014 50 56574 10.1016/j.oraloncology.2013.09.008439170624134947Open DOISearch in Google Scholar

12Mirghani H, Amen F, Tao Y, Deutsch E, Levy A. Increased radiosensitivity of HPV-positive head and neck cancers: molecular basis and therapeutic perspectives. Cancer Treat Rev 2015; 41: 844-52. doi: 10.1016/j.ctrv.2015.10.001Mirghani H Amen F Tao Y Deutsch E Levy A Increased radiosensitivity of HPV-positive head and neck cancers: molecular basis and therapeutic perspectives Cancer Treat Rev 2015 41 844 52 10.1016/j.ctrv.2015.10.00126476574Open DOISearch in Google Scholar

13Wierzbicka M, Szyfter K, Milecki P, Składowski K, Ramlau R. The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies. Contemp Oncol 2015; 19: 313-22. doi: 10.5114/wo.2015.54389Wierzbicka M Szyfter K Milecki P Składowski K Ramlau R The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies Contemp Oncol 2015 19 313 22 10.5114/wo.2015.54389463130726557780Open DOISearch in Google Scholar

14Prevc A, Kranjc S, Cemazar M, Todorovic V, Zegura B, Novak M, et al. Dose-modifying factor of radiation therapy with concurrent cisplatin treatment in HPV-positive squamous cell carcinoma: a preclinical study. Radiat Res 2018; 189: 644-51. doi: 10.1667/RR14984.1Prevc A Kranjc S Cemazar M Todorovic V Zegura B Novak M et al Dose-modifying factor of radiation therapy with concurrent cisplatin treatment in HPV-positive squamous cell carcinoma: a preclinical study Radiat Res 2018 189 644 51 10.1667/RR14984.129652621Open DOISearch in Google Scholar

15Kimple RJ, Harari PM. Is radiation dose reduction the right answer for HPV-positive head and neck cancer? Oral Oncol 2014; 50: 560-4. doi: 10.1016/j.oraloncology.2013.09.015Kimple RJ Harari PM Is radiation dose reduction the right answer for HPV-positive head and neck cancer? Oral Oncol 2014 50 560 4 10.1016/j.oraloncology.2013.09.015398634624134946Open DOISearch in Google Scholar

16Adema AD, Cloos J, Verheijen RHM, Braakhuis BJM, Bryant PE. Comparison of bleomycin and radiation in the G2 assay of chromatid breaks. Int J Radiat Biol 2003; 79: 655-61. doi: 10.1080/09553000310001596968Adema AD Cloos J Verheijen RHM Braakhuis BJM Bryant PE Comparison of bleomycin and radiation in the G2 assay of chromatid breaks Int J Radiat Biol 2003 79 655 61 10.1080/0955300031000159696814555348Open DOISearch in Google Scholar

17O’Connor MJ. Targeting the DNA damage response in cancer. Mol Cell 2015; 60: 547-60. doi: 10.1016/j.molcel.2015.10.040O’Connor MJ Targeting the DNA damage response in cancer Mol Cell 2015 60 547 60 10.1016/j.molcel.2015.10.04026590714Open DOISearch in Google Scholar

18Brown JS, O’Carrigan B, Jackson SP, Yap TA. Targeting DNA repair in cancer: beyond PARP inhibitors. Cancer Discov 2017; 7: 20-37. doi: 10.1158/2159-8290.CD-16-0860Brown JS O’Carrigan B Jackson SP Yap TA Targeting DNA repair in cancer: beyond PARP inhibitors Cancer Discov 2017 7 20 37 10.1158/2159-8290.CD-16-0860530009928003236Open DOISearch in Google Scholar

19Kimple RJ, Smith MA, Blitzer GC, Torres AD, Martin JA, Yang RZ, et al. Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Res 2013; 73: 4791-800. doi: 10.1158/0008-5472.CAN-13-0587Kimple RJ Smith MA Blitzer GC Torres AD Martin JA Yang RZ et al Enhanced radiation sensitivity in HPV-positive head and neck cancer Cancer Res 2013 73 4791 800 10.1158/0008-5472.CAN-13-0587373254023749640Open DOISearch in Google Scholar

20Park JW, Nickel KP, Torres AD, Lee D, Lambert PF, Kimple RJ. Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage. Radiother Oncol 2014; 113: 337-44. doi: 10.1016/j.radonc.2014.08.026Park JW Nickel KP Torres AD Lee D Lambert PF Kimple RJ Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage Radiother Oncol 2014 113 337 44 10.1016/j.radonc.2014.08.026426837225216575Open DOISearch in Google Scholar

21Spanos WC, Nowicki P, Lee DW, Hoover A, Hostager B, Gupta A, et al. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer. Arch Otolaryngol - Head Neck Surg 2009; 135: 1137-46. doi: 10.1001/archoto.2009.159Spanos WC Nowicki P Lee DW Hoover A Hostager B Gupta A et al Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer Arch Otolaryngol - Head Neck Surg 2009 135 1137 46 10.1001/archoto.2009.15919917928Open DOISearch in Google Scholar

22McDermott N, Meunier A, Lynch TH, Hollywood D, Marignol L. Isogenic radiation resistant cell lines: development and validation strategies. Int J Radiat Biol 2014; 90: 115-26. doi: 10.3109/09553002.2014.873557McDermott N Meunier A Lynch TH Hollywood D Marignol L Isogenic radiation resistant cell lines: development and validation strategies Int J Radiat Biol 2014 90 115 26 10.3109/09553002.2014.87355724350914Open DOISearch in Google Scholar

23Todorovic V, Prevc A, Zakelj MN, Savarin M, Brozic A, Groselj B, et al. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines. Radiat Oncol 2019; 14: 1-20. doi: 10.1186/ s13014-019-1418-6Todorovic V Prevc A Zakelj MN Savarin M Brozic A Groselj B et al Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines Radiat Oncol 2019 14 1 20 10.1186/s13014-019-1418-6688234831775835Open DOISearch in Google Scholar

24Harris M, Wang XG, Jiang Z, Goldberg GL, Casadevall A, Dadachova E. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line. Head Neck Oncol 2011; 3: 9. doi: 10.1186/1758-3284-3-9Harris M Wang XG Jiang Z Goldberg GL Casadevall A Dadachova E Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line Head Neck Oncol 2011 3 9 10.1186/1758-3284-3-9304692521314983Open DOISearch in Google Scholar

25Reiss M, Brash D, Muñoz-Antonia T, Simon J, Ziegler A, Vellucci V, et al. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines. Oncol Res 1992; 4: 349-57. PMID:1486218Reiss M Brash D Muñoz-Antonia T Simon J Ziegler A Vellucci V et al Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines Oncol Res 1992 4 349 57 PMID:1486218Search in Google Scholar

26Prevc A, Niksic Zakelj M, Kranjc S, Cemazar M, Scancar J, Kosjek T, et al. Electrochemotherapy with cisplatin or bleomycin in head and neck squamous cell carcinoma: improved effectiveness of cisplatin in HPV-positive tumors. Bioelectrochemistry 2018; 123: 248-54. doi: 10.1016/j.bioelechem.2018.06.004Prevc A Niksic Zakelj M Kranjc S Cemazar M Scancar J Kosjek T et al Electrochemotherapy with cisplatin or bleomycin in head and neck squamous cell carcinoma: improved effectiveness of cisplatin in HPV-positive tumors Bioelectrochemistry 2018 123 248 54 10.1016/j.bioelechem.2018.06.00429898433Open DOISearch in Google Scholar

27Zakelj MN, Prevc A, Kranjc S, Cemazar M, Todorovic V, Savarin M, et al. Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts. Oncol Rep 2019; 41: 1658-68. doi: 10.3892/or.2019.6960Zakelj MN Prevc A Kranjc S Cemazar M Todorovic V Savarin M et al Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts Oncol Rep 2019 41 1658 68 10.3892/or.2019.6960636570530628709Open DOISearch in Google Scholar

28Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034. doi: 10.1186/gb-2002-3-7-research0034Vandesompele J De Preter K Pattyn F Poppe B Van Roy N De Paepe A et al Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 2002 3: RESEARCH0034 10.1186/gb-2002-3-7-research003412623912184808Open DOISearch in Google Scholar

29Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001; 25: 402-8. doi: 10.1006/meth.2001.1262Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001 25 402 8 10.1006/meth.2001.126211846609Open DOISearch in Google Scholar

30Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74. doi: 10.1016/j.cell.2011.02.013Hanahan D Weinberg RA Hallmarks of cancer: the next generation Cell 2011 144 646 74 10.1016/j.cell.2011.02.01321376230Open DOISearch in Google Scholar

31Blasiak J. DNA-damaging anticancer drugs – a perspective for DNA repair-oriented therapy. Curr Med Chem 2017; 24: 1488-503. doi: 10.2174/0929867324666170124145557Blasiak J DNA-damaging anticancer drugs – a perspective for DNA repair-oriented therapy Curr Med Chem 2017 24 1488 503 10.2174/092986732466617012414555728120709Open DOISearch in Google Scholar

32Arenz A, Ziemann F, Mayer C, Wittig A, Dreffke K, Preising S, et al. Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis. Strahlenther Onkol 2014; 190: 839-46. doi: 10.1007/s00066-014-0605-5Arenz A Ziemann F Mayer C Wittig A Dreffke K Preising S et al Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis Strahlenther Onkol 2014 190 839 46 10.1007/s00066-014-0605-524715240Open DOISearch in Google Scholar

33Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-9. doi: 10.1093/jnci/djn011Fakhry C Westra WH Li S Cmelak A Ridge JA Pinto H et al Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 2008 100 261 9 10.1093/jnci/djn01118270337Open DOISearch in Google Scholar

34Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35. doi: 10.1056/NEJMoa0912217Ang KK Harris J Wheeler R Weber R Rosenthal DI Nguyen-Tân PF et al Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 2010 363 24 35 10.1056/NEJMoa0912217294376720530316Open DOISearch in Google Scholar

35Rieckmann T, Tribius S, Grob TJ, Meyer F, Busch C-JJ, Petersen C, et al. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity. Radiother Oncol 2013; 107: 242-6. doi: 10.1016/j.radonc.2013.03.013Rieckmann T Tribius S Grob TJ Meyer F Busch C-JJ Petersen C et al HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity Radiother Oncol 2013 107 242 6 10.1016/j.radonc.2013.03.01323602369Open DOISearch in Google Scholar

36Masterson L, Moualed D, Liu ZW, Howard JEF, Dwivedi RC, Tysome JR, et al. De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials. Eur J Cancer 2014; 50: 2636-48. doi: 10.1016/j.ejca.2014.07.001Masterson L Moualed D Liu ZW Howard JEF Dwivedi RC Tysome JR et al De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials Eur J Cancer 2014 50 2636 48 10.1016/j.ejca.2014.07.00125091798Open DOISearch in Google Scholar

37Blackford AN, Jackson SP. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol Cell 2017; 66: 801-17. doi: 10.1016/j.molcel.2017.05.015Blackford AN Jackson SP ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response Mol Cell 2017 66 801 17 10.1016/j.molcel.2017.05.01528622525Open DOISearch in Google Scholar

38McGowan CH, Russell P. The DNA damage response: sensing and signaling. Curr Opin Cell Biol 2004; 16: 629-33. doi: 10.1016/j.ceb.2004.09.005McGowan CH Russell P The DNA damage response: sensing and signaling Curr Opin Cell Biol 2004 16 629 33 10.1016/j.ceb.2004.09.00515530773Open DOISearch in Google Scholar

39Buisson R, Niraj J, Rodrigue A, Ho CK, Kreuzer J, Foo TK, et al. Coupling of homologous recombination and the checkpoint by ATR. Mol Cell 2017; 65: 336-46. doi: 10.1016/j.molcel.2016.12.007Buisson R Niraj J Rodrigue A Ho CK Kreuzer J Foo TK et al Coupling of homologous recombination and the checkpoint by ATR Mol Cell 2017 65 336 46 10.1016/j.molcel.2016.12.007549677228089683Open DOISearch in Google Scholar

40Leonard BC, Lee ED, Bhola NE, Li H, Sogaard KK, Bakkenist CJ, et al. ATR inhibition sensitizes HPV− and HPV+ head and neck squamous cell carcinoma to cisplatin. Oral Oncol 2019; 95: 35-42. doi: 10.1016/j.oraloncol-ogy.2019.05.028Leonard BC Lee ED Bhola NE Li H Sogaard KK Bakkenist CJ et al ATR inhibition sensitizes HPV− and HPV+ head and neck squamous cell carcinoma to cisplatin Oral Oncol 2019 95 35 42 10.1016/j.oraloncol-ogy.2019.05.028Open DOISearch in Google Scholar

41Sankunny M, Parikh RA, Lewis DW, Gooding WE, Saunders WS, Gollin SM. Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss. Genes Chromosomes Cancer 2014; 53: 129-43. doi: 10.1002/gcc.22125Sankunny M Parikh RA Lewis DW Gooding WE Saunders WS Gollin SM Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss Genes Chromosomes Cancer 2014 53 129 43 10.1002/gcc.22125421659324327542Open DOISearch in Google Scholar

42Wang H, Wang H, Powell SN, Iliakis G, Wang Y. ATR Affecting cell radiosensitivity is dependent on homologous recombination repair but independent of nonhomologous end joining. Cancer Res 2004; 64: 7139-43. doi: 10.1158/0008-5472.CAN-04-1289Wang H Wang H Powell SN Iliakis G Wang Y ATR Affecting cell radiosensitivity is dependent on homologous recombination repair but independent of nonhomologous end joining Cancer Res 2004 64 7139 43 10.1158/0008-5472.CAN-04-128915466211Open DOISearch in Google Scholar

43Bian L, Meng Y, Zhang M, Li D. MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment. Molecular Cancer 2019; 18: 169. doi: 10.1186/s12943-019-1100-5Bian L Meng Y Zhang M Li D MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment Molecular Cancer 2019 18 169 10.1186/s12943-019-1100-5687866531767017Open DOISearch in Google Scholar

44Prati B, da Silva Abjaude W, Termini L, Morale M, Herbster S, Longatto-Filho A, et al. Three Prime Repair Exonuclease 1 (TREX1) expression correlates with cervical cancer cells growth in vitro and disease progression in vivo. Sci Rep 2019; 9: 351. doi: 10.1038/s41598-018-37064-xPrati B da Silva Abjaude W Termini L Morale M Herbster S Longatto-Filho A et al Three Prime Repair Exonuclease 1 (TREX1) expression correlates with cervical cancer cells growth in vitro and disease progression in vivo Sci Rep 2019 9 351 10.1038/s41598-018-37064-x634451830674977Open DOISearch in Google Scholar

45Girard PM, Foray N, Stumm M, Waugh A, Riballo E, Maser RS, et al. Radiosensitivity in nijmegen breakage syndrome cells is attributable to a repair defect and not cell cycle checkpoint defects. Cancer Res 2000; 60: 4881-8. PMID: 10987302Girard PM Foray N Stumm M Waugh A Riballo E Maser RS et al Radiosensitivity in nijmegen breakage syndrome cells is attributable to a repair defect and not cell cycle checkpoint defects Cancer Res 2000 60 4881 8 PMID: 10987302Search in Google Scholar

46Cheng J, Liu W, Zeng X, Zhang B, Guo Y, Qiu M, et al. XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma. Cancer Sci 2015; 106: 1678-86. doi: 10.1111/cas.12820Cheng J Liu W Zeng X Zhang B Guo Y Qiu M et al XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma Cancer Sci 2015 106 1678 86 10.1111/cas.12820471466426383967Open DOISearch in Google Scholar

47Westermark UK, Reyngold M, Olshen AB, Baer R, Jasin M, Moynahan ME. BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks. Mol Cell Biol 2003; 23: 7926-36. doi: 10.1128/mcb.23.21.7926-7936.2003Westermark UK Reyngold M Olshen AB Baer R Jasin M Moynahan ME BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks Mol Cell Biol 2003 23 7926 36 10.1128/mcb.23.21.7926-7936.200320764514560035Open DOISearch in Google Scholar

48Isono M, Niimi A, Oike T, Hagiwara Y, Sato H, Sekine R, et al. BRCA1 directs the repair pathway to homologous recombination by promoting 53BP1 dephosphorylation. Cell Rep 2017; 18: 520-32. doi: 10.1016/j.cel-rep.2016.12.042Isono M Niimi A Oike T Hagiwara Y Sato H Sekine R et al BRCA1 directs the repair pathway to homologous recombination by promoting 53BP1 dephosphorylation Cell Rep 2017 18 520 32 10.1016/j.cel-rep.2016.12.042Open DOISearch in Google Scholar

49Kakarougkas A, Jeggo PA. DNA DSB repair pathway choice: an orchestrated handover mechanism. Br J Radiol 2014; 87: 20130685. doi: 10.1259/bjr.20130685Kakarougkas A Jeggo PA DNA DSB repair pathway choice: an orchestrated handover mechanism Br J Radiol 2014 87 20130685 10.1259/bjr.20130685406459824363387Open DOISearch in Google Scholar

50Litwin I, Pilarczyk E, Wysocki R. The emerging role of cohesin in the DNA damage response. Genes 2018; 9: 581. doi: 10.3390/genes9120581Litwin I Pilarczyk E Wysocki R The emerging role of cohesin in the DNA damage response Genes 2018 9 581 10.3390/genes9120581631600030487431Open DOISearch in Google Scholar

51Basu A, Krishnamurthy S. Cellular responses to cisplatin-induced DNA damage. J Nucleic Acids 2010; 2010: 1-16. doi: 10.4061/2010/201367Basu A Krishnamurthy S Cellular responses to cisplatin-induced DNA damage J Nucleic Acids 2010 2010 1 16 10.4061/2010/201367292960620811617Open DOISearch in Google Scholar

52Marullo R, Werner E, Zhang H, Chen GZ, Shin DM, Doetsch PW. HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells. Carcinogenesis 2015; 36: 1397-406. doi: 10.1093/carcin/bgv126Marullo R Werner E Zhang H Chen GZ Shin DM Doetsch PW HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells Carcinogenesis 2015 36 1397 406 10.1093/carcin/bgv126475124726354779Open DOISearch in Google Scholar

53Harvie RM, Davey MW, Davey RA. Increased MRP expression is associated with resistance to radiation, anthracyclines and etoposide in cells treated with fractionated gamma-radiation. Int J Cancer 1997; 73: 164-7. doi: 10.1002/(SICI)1097-0215(19970926)73:1<164::AID-IJC25>3.0.CO;2-FHarvie RM Davey MW Davey RA Increased MRP expression is associated with resistance to radiation, anthracyclines and etoposide in cells treated with fractionated gamma-radiation Int J Cancer 1997 73 164 7 10.1002/(SICI)1097-0215(19970926)73:1<164::AID-IJC25>3.0.CO;2-FOpen DOISearch in Google Scholar

54McDermott N, Meunier A, Mooney B, Nortey G, Hernandez C, Hurley S, et al. Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells. Sci Rep 2016; 6: 34796. doi: 10.1038/srep34796McDermott N Meunier A Mooney B Nortey G Hernandez C Hurley S et al Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells Sci Rep 2016 6 34796 10.1038/srep34796Open DOISearch in Google Scholar

55Skvortsov S, Dudás J, Eichberger P, Witsch-Baumgartner M, Loeffler-Ragg J, Pritz C, et al. Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC). Br J Cancer 2014; 110: 2677-87. doi: 10.1038/bjc.2014.221Skvortsov S Dudás J Eichberger P Witsch-Baumgartner M Loeffler-Ragg J Pritz C et al Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC) Br J Cancer 2014 110 2677 87 10.1038/bjc.2014.221Open DOISearch in Google Scholar

56Wei QC, Shen L, Zheng S, Zhu YL. Isolation and characterization of radiation-resistant lung cancer D6-R cell line. Biomed Environ Sci 2008; 21: 339-44. doi: 10.1016/S0895-3988(08)60052-5Wei QC Shen L Zheng S Zhu YL Isolation and characterization of radiation-resistant lung cancer D6-R cell line Biomed Environ Sci 2008 21 339 44 10.1016/S0895-3988(08)60052-5Open DOISearch in Google Scholar

57Xie L, Song X, Yu J, Wei L, Song B, Wang X, et al. Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs. J Exp Clin Cancer Res 2009; 28: 68. doi: 10.1186/1756-9966-28-68Xie L Song X Yu J Wei L Song B Wang X et al Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs J Exp Clin Cancer Res 2009 28 68 10.1186/1756-9966-28-68Open DOISearch in Google Scholar

58Kleinsimon S, Longmuss E, Rolff J, Jäger S, Eggert A, Delebinski C, et al. GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway. Sci Rep 2018; 8: 1-14. doi: 10.1038/s41598-018-24075-xKleinsimon S Longmuss E Rolff J Jäger S Eggert A Delebinski C et al GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway Sci Rep 2018 8 1 14 10.1038/s41598-018-24075-xOpen DOISearch in Google Scholar

59Rosemary Siafakas A, Richardson DR. Growth arrest and DNA damage-45 alpha (GADD45α). Int J Biochem Cell Biol 2009; 41: 986-9. doi: 10.1016/j.biocel.2008.06.018Rosemary Siafakas A Richardson DR Growth arrest and DNA damage-45 alpha (GADD45α) Int J Biochem Cell Biol 2009 41 986 9 10.1016/j.biocel.2008.06.018Open DOISearch in Google Scholar

60Wang BX, Yin BL, He B, Chen C, Zhao M, Zhang WX, et al. Overexpression of DNA damage-induced 45 a gene contributes to esophageal squamous cell cancer by promoter hypomethylation. J Exp Clin Cancer Res 2012; 31: 11. doi: 10.1186/1756-9966-31-11Wang BX Yin BL He B Chen C Zhao M Zhang WX et al Overexpression of DNA damage-induced 45 a gene contributes to esophageal squamous cell cancer by promoter hypomethylation J Exp Clin Cancer Res 2012 31 11 10.1186/1756-9966-31-11Open DOISearch in Google Scholar

61Barreto G, Schäfer A, Swaminathan SK, Döderlein G, Maltry N, Stach D, et al. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 2007; 445: 671-5. doi: 10.1038/nature05515Barreto G Schäfer A Swaminathan SK Döderlein G Maltry N Stach D et al Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation Nature 2007 445 671 5 10.1038/nature05515Open DOISearch in Google Scholar

62Tamura R, Vasconcellos JF De, Libermann T, Israel B, Medical D, Fisher PB, et al. GADD45 proteins: central players in tumorigenesis. Curr Mol Med 2012; 12: 634-51. doi: 10.2174/156652412800619978Tamura R Vasconcellos JF De Libermann T Israel B Medical D Fisher PB et al GADD45 proteins: central players in tumorigenesis Curr Mol Med 2012 12 634 51 10.2174/156652412800619978Open DOISearch in Google Scholar

63Liu J, Jiang G, Mao P, Zhang J, Zhang L, Liu L, et al. Down-regulation of GADD45A enhances chemosensitivity in melanoma. Sci Rep 2018; 8: 4111. doi: 10.1038/s41598-018-22484-6Liu J Jiang G Mao P Zhang J Zhang L Liu L et al Down-regulation of GADD45A enhances chemosensitivity in melanoma Sci Rep 2018 8 4111 10.1038/s41598-018-22484-6584142629515153Open DOISearch in Google Scholar

64Zhang X, Xun Qu, Cheng-qin Wang, Cheng-jun Zhou, Gui-xiang Liu, Feng-cai Wei, et al. Over-expression of Gadd45a enhances radiotherapy efficacy in human Tca8113 cell line. Acta Pharmacol Sin 2011; 32: 253-8. doi: 10.1038/aps.2010.208Zhang X Xun Qu Cheng-qin Wang Cheng-jun Zhou Gui-xiang Liu Feng-cai Wei et al Over-expression of Gadd45a enhances radiotherapy efficacy in human Tca8113 cell line Acta Pharmacol Sin 2011 32 253 8 10.1038/aps.2010.208408571721293478Open DOISearch in Google Scholar

65Hollander MC, Sheikh MS, Bulavin D V, Lundgren K, Augeri-henmueller L, Shehee R, et al. Genomic instability in Gadd45a-deficient mice. Nat Genet 1999; 23: 176-84. doi: 10.1038/13802Hollander MC Sheikh MS Bulavin D V Lundgren K Augeri-henmueller L Shehee R et al Genomic instability in Gadd45a-deficient mice Nat Genet 1999 23 176 84 10.1038/1380210508513Open DOISearch in Google Scholar

66Cazzalini O, Scovassi AI, Savio M, Stivala LA, Prosperi E. Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response. Mutat Res 2010; 704: 12-20. doi: 10.1016/j.mrrev.2010.01.009Cazzalini O Scovassi AI Savio M Stivala LA Prosperi E Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response Mutat Res 2010 704 12 20 10.1016/j.mrrev.2010.01.00920096807Open DOISearch in Google Scholar

67Hutchinson MND Mierzwa M, Silva NJ. Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer. Oncogene 2020; 39: 3638-49. doi: 10.1038/s41388-020-1250-3Hutchinson MND Mierzwa M Silva NJ Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer Oncogene 2020 39 3638 49 10.1038/s41388-020-1250-3719057032157215Open DOISearch in Google Scholar

68Sun C, Wang Z, Song W, Chen B, Zhang J, Dai X, et al. Alteration of DNA damage signaling pathway profile in radiation-treated glioblastoma stem-like cells. Oncol Lett 2015; 10:1769-74. doi: 10.3892/ol.2015.3411Sun C Wang Z Song W Chen B Zhang J Dai X et al Alteration of DNA damage signaling pathway profile in radiation-treated glioblastoma stem-like cells Oncol Lett 2015 101769 74 10.3892/ol.2015.3411453329126622748Open DOISearch in Google Scholar

69Zhao J, Jain A, Iyer RR, Modrich PL, Vasquez KM. Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks. Nucleic Acids Res 2009; 37: 4420-9. doi: 10.1093/nar/gkp399Zhao J Jain A Iyer RR Modrich PL Vasquez KM Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks Nucleic Acids Res 2009 37 4420 9 10.1093/nar/gkp399271524919468048Open DOISearch in Google Scholar

70Fu X, Hu J, Han HY, Hua YJ, Zhou L, Shuai W Di, et al. High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy. Oncotarget 2015; 6: 28478-90. doi: 10.18632/oncotarget.4424Fu X Hu J Han HY Hua YJ Zhou L Shuai W Di et al High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy Oncotarget 2015 6 28478 90 10.18632/oncotarget.4424469507326156020Open DOISearch in Google Scholar

71Liu Y, Bernauer AM, Yingling CM, Belinsky SA. HIF1a regulated expression of XPA contributes to cisplatin resistance in lung cancer. Carcinogenesis 2012; 33: 1-6. doi: 10.1093/carcin/bgs142Liu Y Bernauer AM Yingling CM Belinsky SA HIF1a regulated expression of XPA contributes to cisplatin resistance in lung cancer Carcinogenesis 2012 33 1 6 10.1093/carcin/bgs142338849122467238Open DOISearch in Google Scholar

72Leemans C, Braakhuis B, Brakenhoff R. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11: 9-22. doi: 10.1038/nrc2982Leemans C Braakhuis B Brakenhoff R The molecular biology of head and neck cancer Nat Rev Cancer 2011 11 9 22 10.1038/nrc298221160525Open DOISearch in Google Scholar

73Webley K, Bond JA, Jones CJ, Blaydes JP, Craig A, Hupp T, et al. Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol Cell Biol 2000; 20: 2803-8. doi: 10.1128/MCB.20.8.2803-2808.2000Webley K Bond JA Jones CJ Blaydes JP Craig A Hupp T et al Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage Mol Cell Biol 2000 20 2803 8 10.1128/MCB.20.8.2803-2808.20008549610733583Open DOISearch in Google Scholar

74Stiff T, Reis C, Alderton GK, Woodbine L, O’Driscoll M, Jeggo PA. Nbs1 is required for ATR-dependent phosphorylation events. EMBO J 2005; 24: 199-208. doi: 10.1038/sj.emboj.7600504Stiff T Reis C Alderton GK Woodbine L O’Driscoll M Jeggo PA Nbs1 is required for ATR-dependent phosphorylation events EMBO J 2005 24 199 208 10.1038/sj.emboj.760050454491615616588Open DOISearch in Google Scholar